Senseonics Holdings, Inc. engages in the design, development, and commercialization of implantable continuous glucose monitoring system for people with diabetes. Its primary product is the brand Eversense, a gluscose monitoring device which includes sensor, smart transmitter, and mobile application. The company was founded on June 26, 2014 and is headquartered in Germantown, MD.
Company profile
Website
CEO
Timothy T. Goodnow
Employees
Incorporated
Location
Fiscal year end
Industry (SIC)
Former names
Sensors For Medicine & Science Inc
SEC CIK
IRS number
522000730
Latest filings (excl ownership)
S-3ASR
Automatic shelf registration
9 Nov 21
EFFECT
Notice of effectiveness
23 Dec 19
S-3/A
Shelf registration (amended)
18 Dec 19
UPLOAD
Letter from SEC
12 Dec 19
S-3
Shelf registration
27 Nov 19
EFFECT
Notice of effectiveness
23 Sep 19
S-3
Shelf registration
20 Sep 19
UPLOAD
Letter from SEC
18 Sep 19
S-3
Shelf registration
6 Sep 19
D
$12.55M in equity, sold $10M, 10 investors
11 Aug 15
Latest ownership filings